NCT00052416View on ClinicalTrials.gov

Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 2002

Study Completion Date

January 31, 2003

Conditions

LeukemiaLymphoma

Interventions

DRUG

thalidomide

Trial Locations (2)

02215

Beth Israel Deaconess Medical Center, Boston

05401

Fletcher Allen Health Care - University Health Center Campus, Burlington

All Listed Sponsors

lead

Beth Israel Deaconess Medical Center

OTHER

NCT00052416 - Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter